Abbott Initiates Clinical Study for Volt PFA System in Australia for Cardiac Arrhythmias
Abbott (NYSE: ABT) has announced that the first patients have been treated with its Volt...
AbbVie Grants Enigma Biomedical Group Rights to Next-Generation PET Imaging Biomarkers
AbbVie (NYSE: ABBV), a leading pharmaceutical company in the US, has licensed to Canada-based Enigma...
Sichuan Health Commission Issues Directive to Strengthen Oversight of External Prescriptions
The Health Commission of Sichuan Province has issued a notification aimed at enhancing the management...
Shaanxi Panlong Pharmaceutical Partners with Xi’an Medical University for Multifaceted Collaboration
Shaanxi Panlong Pharmaceutical Group Co., Ltd (SHE: 002864), a leading pharmaceutical company based in China,...
Tasly Pharmaceuticals Gets NMPA Go-Ahead for Clinical Trial of Stem Cell Therapy in Heart Failure
Tasly Pharmaceuticals (SHA: 600535), a leading pharmaceutical company in China, has announced that it has...
Sinocelltech Granted NMPA Approval for Phase I Clinical Trial in Hematological Malignancies
Sinocelltech Group Ltd (SHA: 688520), a biopharmaceutical company based in China, has announced that it...
Sanofi’s Dupixent Receives FDA Label Update for Atopic Dermatitis Patients with Hand or Foot Involvement
Sanofi (NASDAQ: SNY) has been granted authorization by the US Food and Drug Administration (FDA)...
Luzhu Biotechnology’s LZ901 Herpes Zoster Vaccine Trial Fully Enrolls 26,000 Participants
Beijing Luzhu Biotechnology Co., Ltd (HKG: 2480), a leading manufacturer of human vaccines and therapeutic...
Danaher Corporation to Establish Northern China Headquarters in Beijing’s Changping District
The Changping District People’s Government of Beijing Municipality has entered into a strategic cooperation agreement...
Glorious Med and Illumina Join Forces for Advanced Urinary Tract Infection Detection
Hangzhou-based Glorious Med, a premier company specializing in gene detection for urinary system tumors, has...
CARsgen Therapeutics’ CT041 Shows Promising Results in Advanced Solid Tumors at ASCO GI 2024
China-based CAR-T cell specialist CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced the presentation of...
Ultrasound Biotechnology Earns FDA Nod for Disposable Endoscopic Ultrasound Probes
Ultrasound Biotechnology, the Shanghai-based wholly owned subsidiary of US firm Ultrasound Wondering, Inc., has announced...
Meinian Onehealth Collaborates with Huawei Cloud and Runda Medical on AI Health Robot
Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a strategic partnership with...
Sinovac Biotech Ltd Dismisses UK Private Equity’s Nominal Share Acquisition Offer
Sinovac Biotech Ltd (NASDAQ: SVA) has released a statement declaring that its board of directors...
Beijing Aosaikang Initiates Phase III Trial for Advanced Gastric Cancer Treatment
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755), a Chinese pharmaceutical company, has registered a Phase...
Zhejiang Dian Diagnostics Partners with Gulf Medical University for Middle East Expansion
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a Chinese diagnostics company, has entered into a...
FDA Approves Casgevy, the First CRISPR-Based Gene Editing Therapy for β-Thalassemia
Casgevy (exagamglogene autotemcel), the pioneering gene editing therapy based on CRISPR technology, has received approval...
Sun Yat-sen University Researchers Develop AI Model for Early Ovarian Cancer Detection
Researchers at Guangzhou’s Sun Yat-sen University Cancer Center have made a significant breakthrough with the...
Shanghai-Based NK CellTech Earns FDA IND Clearance for Non-Genetically Modified NK Cell Therapy
NK CellTech, a Shanghai-based developer of NK cell therapies, has announced that it has received...
Hainan Province Unveils Measures to Support Innovative Drugs and Medical Devices Development
Hainan provincial bureaus, including the Healthcare Security Administration (HSA), Healthcare Commission, and Medical Products Administration,...